Nuclear factor-κB decoys suppress endotoxin-induced lung injury

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 977-979

  Baetz, Delphine ^a   Shaw, James ^a   Kirshenbaum, Lorrie A ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; OLIGONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA; OLIGODEOXYRIBONUCLEOTIDE;

ADULT RESPIRATORY DISTRESS SYNDROME; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR DISEASE; CELL SURVIVAL; DRUG ACTIVITY; HOST CELL; HOST RESISTANCE; HUMAN; IMMUNOSTIMULATION; INFLAMMATION; LUNG INJURY; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; ENDOTOXINS; HUMANS; INFLAMMATION; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RESPIRATORY DISTRESS SYNDROME, ADULT; SIGNAL TRANSDUCTION;

EID: 15744368294     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.011296     Document Type: Review

References (31)

1. Baeuerle PA and Baichwal VR (1997) NF-kappa B as a frequent target for immonosuppressive and anti-inflammatory molecules. Adv Immunol 65:111-137.
2. Baeuerle PA and Baltimore D (1988) I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science (Wash DC) 242:540-546.
3. Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, and Pardee AB (2003) Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res 63:290-295.
4. Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, and Iglehart JD (2004) NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis 1. Proc Natl Acad Sci USA 101:10137-10142.
5. Brand K, Page S, Rogler G, Bartsch A, Brandi R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, and Neumeier D (1996) Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Investig 97:1715-1722.
6. Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, Lekeux P, and Bureau F (2004) Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma 60. J Immunol 173:5766-5775.
7. Ghosh S and Karin M (2002) Missing pieces in the NF-kappaB puzzle. Cell 108 (Suppl):S81-S96.
8. Hansen SK, Nerlov C, Zabel U, Verde P, Johnsen M, Baeuerle PA, and Blasi F (1992) A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene. EMBO (Eur Mol Biol Organ) J 11:205-213.
9. Karin M (1999) The beginning of the end: IκB kinase (IKK) and NF-κB activation. J Biol Chem 274:27339-27342.
10. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, and Karin M (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189:1839-1845.
11. Maniatis T (1999) A ubiquitin ligase complex essential for the NF-kappaB, wnt/wingless and hedgehog signaling pathways. Genes Dev 13:505-510.
12. Matsuda N, Hattori Y, Jesmin S, and Gando S (2005) Nuclear factor-κB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Mol Pharmacol 67:1018-1025.
13. Matsushita H, Morishita R, Nata T, Aoki M, Nakagami H, Taniyama Y, Yamamoto K, Higaki J, Yasufumi K, and Ogihara T (2000) Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 86:974-981.
14. McKinsey TA, Brockman JA, Scherer DC, Al Murrani SW, Green PL, and Ballard DW (1996) Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB. Mol Cell Biol 16:2083-2090.
15. Miyamoto S and Verma IM (1995) Rel/NF-Kappa B/I Kappa B story. Adv Cancer Res 66:255-292.
16. Morishita R and Kaneda Y (2002) HVJ (hemagglutinating virus of Japan; sendai virus)-liposome method 100. Methods Enzymol 346:619-627.
17. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, and Ogihara T (1997) In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction 9. Nat Med 3:894-899.
18. Nabel GJ and Verma IM (1993) Proposed NF-kappa B/I kappa B family nomenclature (Letter). Genes Dev 7:206319.
19. Nolan GP and Baltimore D (1992) The inhibitory ankyrin and activator Rel proteins. Curr Opin Genet Dev 2:211-220.
20. O'Mahony A, Lin X, Geleziunas R, and Greene WC (2000) Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is directional: IKKalpha regulates IKKbeta under both basal and stimulated conditions. Mol Cell Biol 20:1170-1178.
21. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr (1995) Role of Transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science (Wash DC) 270:283-286.
22. Scherer DC, Brockman JA, Chen Z, Maniatis T, and Ballard DW (1995) Signal-induced degradation of I kappa B alpha requires site- specific ubiquitination. Proc Natl Acad Sci USA 82:11259-11263.
23. Schmitz ML and Baeuerle PA (1991) The P65 subunit is responsible for the strong transcription activating potential of NF-kappa B. EMBO (Eur Mol Biol Organ) J 10:3805-3817.
24. Tanaka A, Konno M, Muto S, Kambe N, Morii E, Nakahata T, Itai A, and Matsuda H (2005) A novel NF-κB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated C-kit receptors 18. Blood, in press.
25. Ueno T, Sawa Y, Kitagawa-Sakakida S, Nishimura M, Morishita R, Kaneda Y, Kohmura E, Yoshimine T, and Matsuda H (2001) Nuclear factor-kappa B decoy attenuates neuronal damage after global brain ischemia: a future strategy for brain protection during circulatory arrest 5. J Thorac Cardiovasc Surg 122:720-727.
26. Urban MB and Baeuerle PA (1990) The 65-kD subunit of NF-kappa B Is a receptor for I kappa B and a modulator of DNA-binding specificity. Genes Dev 4:1975-1984.
27. Urban MB and Baeuerle PA (1991) The role of the p50 and p65 subunits of NF-kappa B in the recognition of cognate sequences. New Biol 3:279-288.
28. Van Antwerp DJ and Verma IM (1996) Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Mol Cell Biol 16:6037-6045.
29. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, and Miyamoto S (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-2735.
30. Yokoseki O, Suzuki J, Kitabayashi H, Watanabe N, Wada Y, Aoki M, Morishita R, Kaneda Y, Ogihara T, Futamatsu H, et al. (2001) cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats 7. Circ Res 89:899-906.
31. Zabel U, Henkel T, Silva MS, and Baeuerle PA (1993) Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus. EMBO (Eur Mol Biol Organ) J 12:201-211.